Search

Your search keyword '"Raje, Noopur"' showing total 5 results
Start Over Author "Raje, Noopur" Topic multiple myeloma Publication Year Range Last 10 years Journal journal of the national comprehensive cancer network jnccn
5 results on '"Raje, Noopur"'

1. NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.

Author

Kumar SK, Callander NS, Hillengass J, Liedtke M, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Cornell RF, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Holmberg L, Htut M, Huff CA, Kang Y, Landgren O, Malek E, Martin T, Omel J, Raje N, Sborov D, Singhal S, Stockerl-Goldstein K, Tan C, Weber D, Johnson-Chilla A, Keller J, and Kumar R

Subjects
Humans, Multiple Myeloma
Abstract

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.

Published
2019
Full Text
View/download PDF

2. NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.

Author

Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, Castillo J, Chandler JC, Costello C, Faiman M, Fung HC, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kang Y, Kassim A, Liedtke M, Malek E, Martin T, Neppalli VT, Omel J, Raje N, Singhal S, Somlo G, Stockerl-Goldstein K, Weber D, Yahalom J, Kumar R, and Shead DA

Subjects
Humans, Multiple Myeloma epidemiology, Multiple Myeloma etiology, Multiple Myeloma diagnosis, Multiple Myeloma therapy
Abstract

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines., (Copyright © 2018 by the National Comprehensive Cancer Network.)

Published
2018
Full Text
View/download PDF

3. Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

Author

Kumar SK, Callander NS, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Faiman M, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Liedtke M, Martin T, Omel J, Raje N, Reu FJ, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, and Kumar R

Subjects
Antineoplastic Agents supply & distribution, Antineoplastic Combined Chemotherapy Protocols standards, Asymptomatic Diseases, Chemotherapy, Adjuvant methods, Chemotherapy, Adjuvant standards, Humans, Immunoglobulins blood, Magnetic Resonance Imaging, Maintenance Chemotherapy methods, Maintenance Chemotherapy standards, Multiple Myeloma blood, Myeloma Proteins analysis, Positron Emission Tomography Computed Tomography, Radiotherapy, Adjuvant methods, Radiotherapy, Adjuvant standards, Serologic Tests, Standard of Care, Stem Cell Transplantation standards, Treatment Outcome, Antineoplastic Agents therapeutic use, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Medical Oncology standards, Multiple Myeloma diagnosis, Multiple Myeloma therapy, Stem Cell Transplantation methods
Abstract

Multiple myeloma (MM) is caused by the neoplastic proliferation of plasma cells. These neoplastic plasma cells proliferate and produce monoclonal immunoglobulin in the bone marrow causing skeletal damage, a hallmark of multiple myeloma. Other MM-related complications include hypercalcemia, renal insufficiency, anemia, and infections. The NCCN Multiple Myeloma Panel members have developed guidelines for the management of patients with various plasma cell dyscrasias, including solitary plasmacytoma, smoldering myeloma, multiple myeloma, systemic light chain amyloidosis, and Waldenström's macroglobulinemia. The recommendations specific to the diagnosis and treatment of patients with newly diagnosed MM are discussed in this article., (Copyright © 2017 by the National Comprehensive Cancer Network.)

Published
2017
Full Text
View/download PDF

4. NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.

Author

Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Reu FJ, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, and Kumar R

Subjects
Humans, Multiple Myeloma diagnosis, Multiple Myeloma therapy
Abstract

These NCCN Guidelines Insights highlight the important updates/changes specific to the 2016 version of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma. These changes include updated recommendations to the overall management of multiple myeloma from diagnosis and staging to new treatment options., (Copyright © 2016 by the National Comprehensive Cancer Network.)

Published
2016
Full Text
View/download PDF

5. Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.

Author

Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Singhal S, Smith C, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, and Kumar R

Subjects
Disease Management, Humans, Multiple Myeloma etiology, Multiple Myeloma diagnosis, Multiple Myeloma therapy
Abstract

Multiple myeloma (MM) is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. Recent statistics from the American Cancer Society indicate that the incidence of MM is increasing. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) included in this issue address management of patients with solitary plasmacytoma and newly diagnosed MM., (Copyright © 2015 by the National Comprehensive Cancer Network.)

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results